Related references
Note: Only part of the references are listed.HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway
Weijun Liu et al.
CANCER BIOLOGY & THERAPY (2015)
Oncogenic Properties of Apoptotic Tumor Cells in Aggressive B Cell Lymphoma
Catriona A. Ford et al.
CURRENT BIOLOGY (2015)
Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study
Kumiko Hongo et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis (Publication with Expression of Concern. See vol. 129, pg. 1802, 2019)
Peter Huebener et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma
Jin Cheng et al.
MOLECULAR ONCOLOGY (2015)
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
Antonina V. Kurtova et al.
NATURE (2015)
The multiple facets of drug resistance: one history, different approaches
Evandro Luis Niero et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Inhibition of Aurora B by CCT137690 sensitizes colorectal cells to radiotherapy
Xiaoyu Wu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma
Banzhou Pan et al.
MOLECULAR CANCER (2014)
RAGE in tissue homeostasis, repair and regeneration
Guglielmo Sorci et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation
K. Kono et al.
CELL DEATH & DISEASE (2013)
Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma
Liguo Lin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Western Blot: Technique, Theory, and Trouble Shooting
Tahrin Mahmood et al.
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2012)
Discrimination between primary necrosis and apoptosis by necrostatin-1 in Annexin V-positive/propidium iodide-negative cells
Hirofumi Sawai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy
Qian Huang et al.
NATURE MEDICINE (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Going up in flames: necrotic cell injury and inflammatory diseases
Sreerupa Challa et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
PCNA on the crossroad of cancer
Ivaylo Stolimenov et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Autophagy regulates selective HMGB1 release in tumor cells that are destined to die
J. Thorburn et al.
CELL DEATH AND DIFFERENTIATION (2009)
High-mobility group box 1 (HMGB1) protein: Friend and foe
Luis Ulloa et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas
T Sasahira et al.
VIRCHOWS ARCHIV (2005)
Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer:: A national cancer institute-national surgical adjuvant breast and bowel project collaborative study
CJ Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer
H Kuniyasu et al.
JOURNAL OF PATHOLOGY (2002)
Share Paper
